2m 2m 2m 2m 2m 2m 2m
Axogen (AXGN)
NASDAQ
$58.45+$7.56 (+14.86%)
Price as of Nov 11, 2026 7:56 PM EST- $3.0BMarket Cap
- 108.05%1-Year Change
- Medical DevicesIndustry
Axogen (AXGN)
$58.45+$7.56 (+14.86%)
AXGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $50.89 | ||
Change | +$0.25 (+0.49%) | ||
Open | $49.70 | ||
High | $51.10 | ||
Low | $49.23 | ||
Previous Close | $50.64 | ||
Volume | 1,105,759 | ||
30-Day Average Volume | 1,825,196 | ||
1-Week Change | 2.81% | ||
1-Month Change | 40.85% | ||
1-Year Change | 108.05% | ||
3-Year Change | 913.75% | ||
5-Year Change | 293.58% | ||
Fundamentals | |||
Shares Outstanding | 59.7M | ||
Total Assets | $550.3M | ||
Market Cap | $3.0B | ||
Enterprise Value | $2.7B | ||
Period: QTR TTM FY | |||
Revenue | $75.8M | ||
Net Income | $2.3M | ||
Free Cash Flow | $15.1M | ||
EBIT | $2.3M | ||
EBITDA | $2.5M | ||
Net Working Capital | $401.6M | ||
EPS | $0.04 | ||
Enterprise Value/EBITDA | 1,106 | ||
Enterprise Value/Revenue | 36 | ||
P/B | 6 | ||
P/E | 1,272 | ||
PEG | 5 | ||
Price/Free Cash Flow | 201 | ||
Price/Operating Cash Flow | 184 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 01/27/2010 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue